Validation of the NARCOMS Registry: pain assessment

被引:35
作者
Marrie, RA
Cutter, G
Tyry, T
Hadjimichael, O
Vollmer, T
机构
[1] Cleveland Clin Fdn, Mellen Ctr MS Treatment & Res, Dept Neurol, Cleveland, OH 44195 USA
[2] Univ Alabama, Dept Biostat, Birmingham, AL 35294 USA
[3] Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA
[4] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA
来源
MULTIPLE SCLEROSIS | 2005年 / 11卷 / 03期
关键词
multiple sclerosis; pain; registry; reliability; self-report; validity;
D O I
10.1191/1352458505ms1167oa
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The North American Research Committee on Multiple Sclerosis (NARCOMS) Registry is a multiple sclerosis (MS) self-report registry with more than 24 000 participants. Participants report disability status upon enrolment, and semi-annually using Performance Scales (PS), Patient Determined Disease Steps (PDDS) and a pain question. In November 2000 and 2001, we also collected the Pain Effects Scale (PES). Our aim was to validate the NARCOMS pain question using the PES as our criterion measure. We measured correlations between the pain question and age, disease duration, various PS subscales and PDDS to assess construct validity. We correlated pain question responses in participants who reported no change in PDSS or the PS subscales between questionnaires to determine test-retest reliability. We measured responsiveness in participants who reported a substantial change in the sensory, spasticity PS subscales. The correlation between the pain question and PES was r = 0.61 in November 2000, and r = 0.64 in November 2001 (both P < 0.0001). Correlations between the pain question and age, and disease duration were low, indicating divergent validity. Correlations between the pain question and spasticity sensory PS subscales and PDSS were moderate, indicating convergent validity. Test-retest reliability was r = 0.84 (P < 0.0001). Responsiveness was 70.7%. The pain question is a valid self-report measure of pain in MS.
引用
收藏
页码:338 / 342
页数:5
相关论文
共 17 条
[1]   PAIN PREVALENCE, SEVERITY AND IMPACT IN A CLINIC SAMPLE OF MULTIPLE-SCLEROSIS PATIENTS [J].
ARCHIBALD, CJ ;
MCGRATH, PJ ;
RITVO, PG ;
FISK, JD ;
BHAN, V ;
MAXNER, CE ;
MURRAY, TJ .
PAIN, 1994, 58 (01) :89-93
[2]  
Benrud-Larson LM, 2000, NEUROREHABILITATION, V14, P127
[3]  
COLLINS JC, 1993, VITAL HLTH STAT, V10
[4]   Chronic pain in a large community sample of persons with multiple sclerosis [J].
Ehde, DM ;
Gibbons, LE ;
Chwastiak, L ;
Bombardier, CH ;
Sullivan, MD ;
Kraft, GH .
MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (06) :605-611
[5]  
Elliott Alison M, 2003, Expert Rev Neurother, V3, P581, DOI 10.1586/14737175.3.5.581
[6]   Recent developments in the assessment of quality of life in Multiple Sclerosis (MS) [J].
Fischer, JS ;
LaRocca, NG ;
Miller, DM ;
Ritvo, PG ;
Andrews, H ;
Paty, D .
MULTIPLE SCLEROSIS JOURNAL, 1999, 5 (04) :251-259
[7]   DISEASE STEPS IN MULTIPLE-SCLEROSIS - A SIMPLE APPROACH TO EVALUATE DISEASE PROGRESSION [J].
HOHOL, MJ ;
ORAV, EJ ;
WEINER, HL .
NEUROLOGY, 1995, 45 (02) :251-255
[8]   A profile of multiple sclerosis: The New York State Multiple Sclerosis Consortium [J].
Jacobs, LD ;
Wende, KE ;
Brownscheidle, CM ;
Apatoff, B ;
Coyle, PK ;
Goodman, A ;
Gottesman, MH ;
Granger, CV ;
Greenberg, SJ ;
Herbert, J ;
Krupp, L ;
Lava, NS ;
Mihai, C ;
Miller, AE ;
Perel, A ;
Smith, CR ;
Snyder, DH .
MULTIPLE SCLEROSIS JOURNAL, 1999, 5 (05) :369-376
[9]  
Jensen MP, 1992, Handbook of Pain Assessment, P135
[10]   Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis [J].
Marrie, RA ;
Miller, DM ;
Chelune, GJ ;
Cohen, JA .
MULTIPLE SCLEROSIS, 2003, 9 (06) :621-626